Three Indian states have issued temporary bans on the sale of Coldrif cough syrup following investigations into potential toxic substances. The state governments announced the measures following reports of nine children suffering adverse health effects linked to the syrup. Testing has confirmed the presence of contaminants within the product. Authorities are investigating the source of these contaminants and implementing measures to prevent further incidents. The states are currently reviewing protocols to ensure consumer safety and address the ongoing concerns. The ban is temporary, and the exact duration remains to be determined.
Credits: India Today | India
